Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
TAUVID save search
How retailers and “payviders” are disrupting U.S. healthcare in 2024
Published: 2024-04-19 (Crawled : 08:00) - clarivate.com
LHCG | $169.81 0.47% -0.03% 0
|
Health Services
| Email alert
Add to watchlist
Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
IMUX | $1.23 4.24% 3.28% 170K
|
Health Technology
|
| O: 0.71%
H: 4.26%
C: 3.9%
trials
Nauticus Robotics to Provide AUV/UID Leak Detection Technology Testing for Equinor
Published: 2023-08-29 (Crawled : 12:00) - globenewswire.com
KITT | $0.201 -6.64% -5.85% 220K
|
|
| O: 1.46%
H: 1.92%
C: 1.92%
STOHF | News | $28.0 -3.74% 340
|
Energy Minerals
|
| O: 3.23%
H: 0.0%
C: -3.49%
EQNR | News | $27.13 -0.66% -0.33% 3.1M
|
Energy Minerals
|
| O: 0.56%
H: 1.61%
C: 1.38%
technology
Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial
Published: 2021-02-17 (Crawled : 12:11) - prnewswire.com
IMUX | $1.23 4.24% 3.28% 170K
|
Health Technology
|
| O: -10.32%
H: 1.3%
C: -10.58%
covid treatment phase 2 trial imu-838
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.